Simpler Grants.gov #HT942526LCRPPCOSA

Army Seeks Research Proposals for Lung Cancer Patient-Centered Outcomes and Survivorship

The Dept. of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is inviting research proposals for the Lung Cancer Patient-Centered Outcomes and Survivorship Award (PCOSA), funded by the Congressionally Directed Medical Research Programs (CDMRP). - Opportunity focuses on evidence-based, patient-centered research to improve health and outcomes for lung cancer patients - Projects must address at least one area of emphasis in Health Outcomes and Survivorship - Mandatory inclusion of a lung cancer patient/survivor or caregiver advocate on the research team - Eligible research includes translational or clinical studies, such as pilot clinical trials - Funding instrument is a grant, not a product or service procurement - Approximately $1.95 million available, with up to two awards of $975,000 each - Maximum period of performance is three years per award - Eligible applicants include domestic and foreign, for-profit and nonprofit, public or private organizations - No specific OEMs or vendors are named, as this is a research grant opportunity

Government Buyer: - Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Funding entity: Congressionally Directed Medical Research Programs (CDMRP)

Notable Requirements: - Inclusion of a lung cancer patient/survivor or caregiver advocate in the research team - Focus on patient-centered outcomes and survivorship in lung cancer research - Open to a wide range of applicant organizations

Description

The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category. This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver and allows proposed projects to include translational or clinical research, including pilot clinical trials. The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $1.95 million to fund approximately two PCOSA applications with total cost caps of $975,000 per award and a maximum period of performance of 3 years.

View original listing